Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

Genetic testing revealed both had the BRCA gene – one that puts someone at higher risk of developing breast and ovarian cancers – something they were previously unaware of. But it's not ...

The findings have immediate implications for genetic testing laboratories and health ... "We now have a catalog of every possible VUS in this part of BRCA2 that can be used to guide clinical ...

For years, breast cancer treatment has been guided by genetic alterations found in tumor tissue, typically through invasive biopsies.

Testing for BRCA mutations linked to breast and ovarian cancers could become easier and more accessible with the help of artificial intelligence, potentially allowing earlier treatment.

Table 2. Indications for Genetic Testing for Germ Line Mutations in BRCA1 and BRCA2 Testing for germ line mutations in BCRA1 and BCRA2 is indicated for individuals with any of the following ...

Jewish people in England are being invited to take part in a gene testing programme to identify carriers of BRCA mutations that elevate their risk of breast cancer. The NHS Jewish BRCA Testing ...

Vanessa Feltz has undergone testing for the BRCA gene mutation. The 62-year-old broadcaster's mum died of cancer after being diagnosed "too late" so she and her whole family have undergone screening ...